Navigation Links
Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar

INDIANAPOLIS, Sept. 21 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced that Lauren Marangell, M.D., will join Lilly in November 2007, as a Distinguished Lilly Scholar focusing on depression and related disorders.

"We are delighted to recruit someone with Dr. Marangell's stature and depth of experience to join Lilly," said Jack Harris, M.D., vice president, U.S. medical division. "Lauren brings a national and international reputation in depression and other mood disorders. This experience will allow her to play a key scientific leadership role in our relationships with the U.S. healthcare community and the broader clinical and scientific community, providing quality information regarding Lilly products and research."

Marangell joins Lilly from Baylor College of Medicine where she is Brown Foundation Chair in psychopharmacology of mood disorders, professor of psychiatry with tenure and director of mood disorders research. At Baylor, she developed a state-of-the-art mood disorders research program recognized as one of the most successful in the country. She has held numerous national and international leadership positions and is a scientific reviewer for most major journals in the field. In addition to her success in research, Marangell is well known as a prominent clinician and educator. Among many awards of note, she is a recipient of the "Exemplary Psychiatrist Award" from the National Alliance for the Mentally Ill, and is listed in "Who's Who Among American Educators." She is first author of the "Concise Guide to Psychopharmacology", with coauthor James Martinez, M.D., now also with Lilly.

"I am very excited that Lauren chose to join Lilly," said John Hayes, M.D., vice president, global brand development platform leader - neuroscience. "She is a world-class physician who will provide significant understanding of the external environment and key insights to Lilly's drug development programs. She is an outstanding addition to Lilly's research team."

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at


(Logo: )

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Thailand To Procure Botulism Antitoxin Internationally
2. Time magazine has recognized efforts of two Indian doctors towards reducing infant mortality rate
3. Nurse Practitioners Are Not Recognized By Medicare
4. Scientist Recognized for Drug Addiction Research
5. Medical Center Recognized for Excellence in Bariatric Surgery
6. A young scientist recognized for biomechanics innovations
7. Distinguishable Traits of Fatal Skin Cancer Recognized
8. Bipolar Spectrum Disorder may Be Under-recognized for Spectrum Disorder: Study
9. Smoking a greater risk than HIV? Yes say health experts!!!!
10. Roche offers HIV drug expertise to poor nations
11. Good carb, bad carb? Experts debate.
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... On Tuesday 27 ... NASDAQ to educate the personnel on spinal decompression therapy and offer his professional ... nonsurgical procedure. The benefits come from creating negative intradiscal pressure which is conducive ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... rural West Tennessee to receive Gigabit Internet through a partnership this year with ... largest cities, Henderson is an attractive destination for entrepreneurs who want to build ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... Florida Hospital Tampa is the ... of obesity in the state of Florida. , vBloc® Therapy is a vagal blocking therapy, ... 18 years with a body mass index (BMI) of at least 40 to 45 kg, ...
(Date:12/1/2015)... ... ... Califia Farms , one of the fastest growing natural beverage companies ... in Beverage World Magazine’s Global Packaging Design Awards, taking home the Gold in the ... a 2015 U.S.A. Taste Champion in the American Masters of Taste Championships for its ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015 ... of the company’s growing product line of food safety and seafood fraud prevention ... (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable species identification for the ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... WellStar Health System has signed a definitive ... Tenet Healthcare,s five metro Atlanta ... move following the conclusion of the due diligence period. ... and patient safety programs that have resulted in increased ... --> --> With ...
(Date:12/1/2015)... 2015  Eyeon Therapeutics has received a Notice ... based on a charged hydrophilic polymer developed at ... product has been shown to be safe and ... Mark Mitchnick , MD, CEO states, "This second ... polymers in conjunction with a therapeutic agent.  Nanoparticles ...
(Date:12/1/2015)... , Dec. 1, 2015 Pharma Tech Outlook ... Top 10 Clinical Data Management Solution Providers - 2015 ... distinguished panel comprising CEOs, CIOs, VCs, analysts, and the ... illustrious list of top 10 clinical data management solution ... on pages 14 and 36 respectively). ...
Breaking Medicine Technology: